Maia Vinogradova

Title: Maia Vinogradova: Innovator in Conditional Bispecific Redirected Activation Constructs

Introduction

Maia Vinogradova is a prominent inventor based in Moraga, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic constructs. With a total of 5 patents to her name, her work focuses on advancing cancer treatment methodologies.

Latest Patents

One of her latest patents is centered around constrained conditionally activated binding proteins. This invention relates to Conditional Bispecific Redirected Activation constructs, or COBRAs, which are administered in an active pro-drug format. Upon exposure to tumor proteases, these constructs are cleaved and activated, allowing them to bind both tumor target antigens (TTAs) and CD3. This mechanism effectively recruits T cells expressing CD3 to the tumor, resulting in targeted treatment.

Career Highlights

Maia Vinogradova is currently associated with Takeda Pharmaceutical Company Limited, where she continues to push the boundaries of medical innovation. Her work is instrumental in developing therapies that can significantly improve patient outcomes in oncology.

Collaborations

Throughout her career, Maia has collaborated with notable professionals in her field, including Robert B Dubridge and Anand Panchal. These collaborations have further enriched her research and development efforts.

Conclusion

Maia Vinogradova stands out as a leading inventor in the realm of biotechnology, particularly in the development of innovative cancer therapies. Her contributions are paving the way for more effective treatments and showcasing the potential of conditional bispecific redirected activation constructs.